Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with

B Fevang1, T E Mollnes, A M Holm

  • 1Research Institute for Internal Medicine, University of Oslo, Rikshospitalet University Hospital, N-0027 Oslo, Norway. Borre.Fevang@medisin.uio.no

Clinical and Experimental Immunology
|November 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An international perspective on allocation rules for combined heart-lung transplantation.

JHLT open·2026
Same author

High levels of the adipokines leptin and metrnl in patients with paroxysmal atrial fibrillation and obstructive sleep apnea are not associated with the severity of sleep apnea or the burden of atrial fibrillation.

Sleep medicine·2025
Same author

Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?

International journal of cardiology·2025
Same author

Reply to: Letter regarding the study by Nilsen et al. on IL-1RA and 5-Year Mortality Risk: Redefining the Threshold for high admission levels of IL-1RA.

International journal of cardiology·2025
Same author

Reply to: Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients.

International journal of cardiology·2025
Same author

Reply to: Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.

International journal of cardiology·2025

Common variable immunodeficiency patients show increased complement activation, not deficiencies. Mannose-binding lectin and the lectin complement pathway may protect against respiratory infections and bronchiectasis.

Area of Science:

  • Immunology
  • Infectious Diseases

Background:

  • The role of innate immunity, specifically mannose-binding lectin (MBL) and the complement system, in common variable immunodeficiency (CVID) remains incompletely understood.
  • Investigating these components is crucial for understanding CVID pathogenesis and identifying potential therapeutic targets.

Purpose of the Study:

  • To assess MBL and complement system status in CVID patients.
  • To correlate these findings with clinical and immunological parameters, including autoimmunity and infection frequency.

Main Methods:

  • Quantified MBL levels, complement components, and activation products in 71 CVID patients and 30 healthy controls.
  • Assessed functional capacity of classical, alternative, and lectin complement pathways.
  • Correlated immunological findings with clinical data, such as infection history and autoimmunity.

Related Experiment Videos

Main Results:

  • CVID patients exhibited increased complement activation, linked to autoimmunity and immune hyperactivity.
  • No deficiencies were found in classical or alternative complement pathways.
  • Lower lectin pathway capacity was observed in patients with frequent respiratory infections or bronchiectasis.
  • Lower MBL serum concentration correlated with increased respiratory infections and bronchiectasis.

Conclusions:

  • CVID patients do not present with increased complement deficiencies but show signs of heightened complement activation.
  • MBL and the lectin complement pathway appear to offer protection against lower respiratory tract infections and bronchiectasis in CVID.
  • These findings highlight the potential protective role of the lectin pathway in CVID management.